
Several new drug therapies with beneficial effects on more than one of the zzso risk factors that contribute to the zzso syndrome have been developed recently or are under zzso Emerging risk factors for coronary heart disease zzso including low zzso of zzso zzso zzso cholesterol and zzso zzso zzso high levels of zzso zzso zzso and small dense zzso zzso cholesterol zzso have been zzso We provide a detailed description of the mechanisms of action and findings from clinical trials of the new drug therapies and discuss established drug therapies with beneficial effects on emerging risk factors for zzso The new and emerging drug therapies include an zzso agent that reduces zzso zzso and abnormal zzso zzso zzso zzso transfer protein zzso that increase HDL cholesterol and zzso zzso zzso that increase HDL cholesterol and decrease zzso zzso as well as improve abnormal zzso zzso and the zzso analog zzso and the zzso zzso zzso both of which reduce body weight as well as improve abnormal zzso zzso The zzso effects of zzso zzso zzso and zzso II zzso zzso zzso which may help prevent zzso diabetes zzso and the beneficial effects of the zzso zzso on the zzso and zzso profiles also are zzso 

